Purchase Order 75N95025P00079
Award Date
12/31/24
Potential Completion Date
12/30/25
Potential Value
$92K
Funding Federal Agency
National Institute on Aging
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Alamar Biosciences, Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fremont, CA 94538, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency, to Alamar Biosciences, Inc. for the ALAMAR NULISASEQ INFLAMMATION PANEL 250 REAGENTS. The contract has a ceiling value of $324,000.00 and a period of performance through July 7, 2025. Alamar Biosciences, Inc. is a for-profit manufacturer of specialized biomedical research tools and services, with a focus on diagnostic technologies for central nervous system disorders like...
This is a $20,000.00 firm fixed-price purchase order contract awarded by the National Institute of Mental Health (NIMH), a civilian agency, to Alamar Biosciences, Inc., a for-profit manufacturer of goods. The contract has a performance period ending on June 23, 2026 and was awarded on June 24, 2025. The contract does not have a set-aside designation, indicating Alamar Biosciences successfully competed for this open market procurement. The award is focused on providing specialized research...
This is a firm-fixed-price purchase order award to Alamar Biosciences, Inc. by the National Institute on Aging (NIA), a civilian agency, for $247,000.00. The contract is for providing proteomic analysis services, including the NULISAseq CNS Disease Panel 120 assay, next-generation sequencing, and bioinformatic support for 1,118 plasma samples. The purpose is to identify biomarkers that can be used to classify and stage Alzheimer's disease. This award is not associated with a set-aside and is the...
This is a $100,000.00 firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian federal agency, to Alamar Biosciences, Inc., a for-profit manufacturer of goods located in Fremont, California. The contract is for the provision of the NULISASEQ MOUSE PANEL, which involves proteomic mouse panel analysis to investigate potential biomarkers. The award does not have a set-aside designation, indicating open market competition. The contract period runs from...
<p>The National Institute on Aging, a civilian federal agency, awarded a $17,500.00 Firm Fixed Price Purchase Order to Alamar Biosciences, Inc. to provide laboratory and testing services for the NULISASEQ CNS Disease Panel service. The award has an ultimate completion date of August 11, 2024. The contract does not have a set-aside designation.</p>
This $1,786,400.00 firm fixed price purchase order contract was awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Amprion, Inc., a for-profit company specializing in neurological diagnostic services. The contract is for protein analysis services focused on detecting alpha-synuclein aggregates in cerebrospinal fluid samples, utilizing Amprion's proprietary SYNTap assay technology. The contract has a period of...
The National Institute on Aging (NIA) awarded a $97,757.34 firm fixed-price purchase order to Fujirebio US, Inc. to provide assay kits for the Lumipulse G1200 instrument. The purpose is to leverage existing data on neuroimaging, cognitive, and clinical factors to understand cognitive and brain changes in healthy individuals and those with comorbidities. The original sources sought notice indicated the government was looking to acquire state-of-the-art assay kits for quantification of...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $107,238.60 firm fixed price purchase order to Quanterix Corporation, a for-profit manufacturer, for Simoa 4-plex 96-well plate assays to quantify serum/plasma biomarkers for Alzheimer's disease research. The assays will be used to analyze samples from participants in the Baltimore Longitudinal Study of Aging and the Genetic and Epigenetic Signatures of Translational Aging Laboratory...
The National Institute on Drug Abuse (NIDA), on behalf of the National Institute on Aging (NIA), awarded a $30,000.00 firm-fixed-price purchase order to Alamar Biosciences, Inc. to provide three 120 CNS kits to be used on the Alamar NULISA platform. These kits contain over 120 disease markers and will support research by the NIA's Laboratory of Clinical Investigation into biomarkers of neurodegenerative diseases found in exosomes isolated from patients' plasma. The award is a sole-source...
This federal contract award was made by the National Institute on Aging (NIA), a civilian agency under the Department of Health and Human Services (HHS), to the prime contractor 10X Genomics, Inc. The $14,446.50 fixed-price delivery order contract is for the provision of LABORATORY SUPPLIES - GEM-X CHROMIUM CELL KITS. 10X Genomics, a for-profit manufacturer of life sciences products and services, will deliver these single-cell analysis kits to support the NIA's biomedical research efforts,...